WO2014104577A1 - Composition including castor oil extracted from castor beans using hexane, undecylenic acid, propyl alcohol, propylene glycol, and water for external use on skin for preventing or treating athlete's foot - Google Patents

Composition including castor oil extracted from castor beans using hexane, undecylenic acid, propyl alcohol, propylene glycol, and water for external use on skin for preventing or treating athlete's foot Download PDF

Info

Publication number
WO2014104577A1
WO2014104577A1 PCT/KR2013/010516 KR2013010516W WO2014104577A1 WO 2014104577 A1 WO2014104577 A1 WO 2014104577A1 KR 2013010516 W KR2013010516 W KR 2013010516W WO 2014104577 A1 WO2014104577 A1 WO 2014104577A1
Authority
WO
WIPO (PCT)
Prior art keywords
foot
athlete
castor oil
composition
hexane
Prior art date
Application number
PCT/KR2013/010516
Other languages
French (fr)
Korean (ko)
Inventor
전상문
Original Assignee
Jean Sang Moon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean Sang Moon filed Critical Jean Sang Moon
Publication of WO2014104577A1 publication Critical patent/WO2014104577A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Definitions

  • the present invention relates to a skin external preparation composition for athlete's foot prevention or treatment containing castor oil extracted from hexane, undecylenic acid, propyl alcohol, propylene glycol and water.
  • Athlete's foot (tinea pedis) is one of the most common symptoms of fungal infections. It is a parasitic and multiplying skin disease in which the fungus dissolves the keratin of the skin and nourish it. Among the fungi having affinity for the skin, trichophyton rubrum , Trichophyton mentagrophytes , Microsporum canis , Candida albicans , etc. They penetrate the keratin of the skin and cause symptoms such as itching, redness, and inflammation. The exacerbation of these fungal infections is known to depend on the environment at the site of infection and the individual's ability to immunize. On the other hand, the modern society mainly wears shoes or socks for a long time. After the infection of the fungus, if the skin is kept closed for a long time by the shoes and socks, the fungus proliferates due to heat and moisture of the infected area. This improves, and athlete's foot occurs.
  • Athlete's foot is found in most parts of the body in funky, keratin-rich, moist, warm areas (toes, soles, toenails, nails, flanks, groin, and flesh).
  • more than 10% of the total population suffers from athlete's foot, most frequently in their 20s and 40s. Rarely occurs in children.
  • Athlete's foot is divided into a basal, hydrophobic, and keratinous form depending on the developmental form.
  • the interstitial type occurs mainly between the toes, because the area is not easily communicated with the outside air and the moisture is high, so the fungus is easily inhabited.
  • the intercostal athlete's foot occurs, itching is severe, the skin is whitened and cracked, causing an unpleasant odor, and sometimes spreads to both toes and soles.
  • blisters of various sizes are produced, and when it is scratched due to itching, the skin is peeled off frequently, and a lot of sweat is known to deteriorate a lot during the summer sweating.
  • Athlete's foot-type athlete's foot is thickened over the entire sole of the foot and thick, which means that the powder falls. It is easy to develop into chronic refractory athlete's foot.
  • fungi can penetrate into other parts of the body, such as insteps or toenails, and develop into nail footing.
  • Nail athlete's foot is a symptom of fungal infection of the toenails or nails, which causes thick keratinization and color change in the nails, and the nails crumble when they progress.
  • the recent increase in the elderly population and the use of swimming pools or gym spas Increasingly, the likelihood of exposure to athlete's foot fungi increases.
  • baekbueum occurs in the groin completeness, mainly due to high temperature and high humidity skin conditions, obesity, close clothing and friction between the skin and the skin caused by the athlete's foot fungus is inhabited and accompanied by foot athlete's foot There are many cases. Athlete's foot athlete's foot fungus is usually buried in the inner part of the body, most often occur in men, scrotum, buttocks, thighs are also spread. The condition worsens mainly in wet summers, leaving only black pigmentation in dry winters, and most of the main symptoms disappear. It occurs almost in both groin.
  • the onset begins at the point where the testis touches and then spreads to both groin, and red keratin may begin in the testicle or penis bone without groin invasion.
  • red keratin may begin in the testicle or penis bone without groin invasion.
  • the reason why groin completeness is significantly better in men than in women is because men wear more sealed clothing than women, testicles are more sealed in the groin, and men have a higher frequency of foot athlete's foot.
  • foot odor is a form of bromidrosis that occurs on the soles of the feet.
  • the soles of the feet have a lot of eccrine gland, which is more sweaty than other skin tissues.
  • eccrine gland As the keratin tissue of the warp is distorted, bacteria and fungi inhabit, causing foot odor.
  • Drunkenness most often occurs on the soles of the feet, but sometimes occurs in other parts of the body, such as the interrogator, or the fold of flesh.
  • Foot odor is most common in young men and middle-aged adults, but there are no statistically significant race differences or gender differences. Foot odor occurs regardless of the season, because the sweat on the sole is caused by emotional tension, not due to a rise in body temperature.
  • the anxiety of foot odor may make patients more nervous, causing stress symptoms that worsen foot odor and lead to social activity.
  • athlete's foot tends to recur if not properly rooted, so it often becomes 'companion disease' that must live together for a lifetime.
  • Athlete's foot is suddenly itchy at the beginning of the rainy season.
  • Athlete's most probable environment is the temperature of 37 °C, moderate humidity, nutrients, etc., summer has all of these conditions, so the athlete's fungus multiplies and rises in summer.
  • athlete's foot sticks to the skin even in winter, but the activity is weakened, but the bacteria that boasted strong breeding ability in the humid and warm environment cannot hide well in the winter and hide in the skin.
  • a method of killing athlete's foot causing bacteria or inhibiting the growth of bacteria is considered.
  • the most commonly used therapeutics include antifungal agents, which are used because they are easy to use and have fewer side effects. However, it is difficult to cure only by using a coating agent, and it is common to apply at least several weeks. Next, there is an antifungal drug to eat, the effect of the treatments are good compared to the drug, but side effects such as hepatotoxicity, nephrotoxicity, etc. rarely occurs, so care should be taken in the administration.
  • Terbinafine has excellent sterilizing effect and has the advantage of being able to see a quick effect in a short time.
  • Clotrimazole focuses on slow treatment rather than sterilization. Although treatment with clotrimazole takes a long time, it is known to have an advantage over terbinafine products for restoring damaged skin.
  • the drugs are mainly manufactured in cream or ointment type, but they are good for use in the condition that the keratin is severe and becomes hard like a callus.
  • athlete's foot athletes are usually relapsed even after the appearance of symptoms after treatment, it is difficult to cure if not treated steadily, there is a need for a new type of athlete's foot treatment agent excellent safety and athlete's foot treatment effect without side effects.
  • Castor oil is a fatty oil obtained by squeezing the seeds of Ricinus communis , also known as castor oil.
  • Castor oil contains ricinoleic acid, palmitic acid, stearic acid, linolenic acid, hydroxystearic acid, trilinolein, and diricinoleine.
  • diricinolein monooricinolein
  • ricinoleic acid ricinoleic acid
  • undecylenic acid undecylenic acid
  • Castor oil is often taken as a laxative or as a fungicide. It has a burn treatment effect and an excellent antipyretic effect.
  • Undecylenic acid is an active compound of castor oil and is known to have antibacterial, deodorant and fungicidal action.
  • the inventors of the present invention while studying the athlete's foot treatment composition containing castor oil and undecylenic acid extracted using hexane is Trichophyton rubrum ( KCTC 6345), Trichophyton mentagrophytes (KCTC) 6077), Microsporum canis (KCTC 6348), Candida albicans ( Candida albicans , KCTC 7965) by confirming the excellent antifungal effect was able to complete the present invention.
  • undecylenic acid may be used as an athlete's foot therapeutic agent
  • Korean Patent No. 500577 and US Patent No. 7186416 castor oil may be used as a therapeutic agent for treating athlete's foot athlete's foot.
  • it is disclosed that it can be used as a component it has not been confirmed at all about the external skin composition for athlete's foot treatment containing undecylenic acid and castor oil, or castor oil extracted using hexane.
  • An object of the present invention is to provide a composition for external athlete's foot for preventing or treating athlete's foot, which contains castor oil, undecylenic acid, propyl alcohol, propylene glycol and water extracted from castor hexane.
  • the present invention relates to a skin external preparation composition for athlete's foot prevention or treatment containing castor oil extracted from hexane, undecylenic acid, propyl alcohol, propylene glycol and water.
  • the skin external preparation composition for athlete's foot prevention or treatment castor oil extracted from hexane 0.5 ⁇ 2% by weight, undecylenic acid 7 ⁇ 11% by weight, propyl alcohol 30 ⁇ 50% by weight, propylene glycol 15 ⁇ 35% by weight and water It may contain 15 to 35% by weight.
  • the skin external preparation composition for preventing or treating athlete's foot may be a composition having a pH of 6.0 to 6.5 using a triethanolamine solution.
  • the athlete's foot is from a fungus selected from the group consisting of Trichophyton rubrum , Trichophyton mentagrophytes , Microsporum canis and Candida albicans It is characterized in that the disease is induced.
  • composition is preferably,
  • Step 1 Mixing a castor (seeds of Ricinus communis ) ground with normal hexane and stirring at 15 ⁇ 27 °C;
  • Step 2 collecting the remaining castor oil after removing the solid content from the stirring and separating the remaining hexane by the concentrated vacuum method using a heated bath;
  • Step 3 0.5 to 2% by weight of castor oil extracted from the hexane, 7 to 11% by weight undecylene acid, 30 to 50% by weight of propyl alcohol, 15 to 35% by weight of propylene glycol and 15 to 35% by weight of water Mixing and stirring;
  • the castor pulverized product may be extracted with normal hexane to obtain castor oil corresponding to 25 to 45 wt% of the weight of the castor pulverized product.
  • Normal hexane may be added 2 to 20 times (w / v) of the weight of the castor.
  • the mixture of the three steps is mixed evenly in the solution state of the clear and transparent state by adding the triethanolamine solution.
  • triethanolamine is used as a neutralizing agent for the mixing of each component of the composition, in addition, it serves as a surfactant, detergent and insect repellent in the composition.
  • composition of the present invention is used as an external preparation for skin, it is better to avoid the application to a weak spot such as around the eye.
  • composition of the present invention can be used as a therapeutic agent for skin fungus, such as athlete's foot, mainly used as a liquid type skin coating, and may be processed and used in sprays, ointments, creams, lotions, patches.
  • composition of the present invention can also be used as additives such as cleaning agents, disinfectants.
  • composition of the present invention may further include a physiologically acceptable carrier according to the formulation and the method of use, it may be included in 1.0 to 99.9% by weight of the total external skin composition for athlete's foot prevention or treatment.
  • the dosage of the composition is preferably adjusted according to the severity of athlete's foot symptoms and the health of the patient.
  • the composition of the present invention relates to a composition for external athlete's foot for preventing or treating athlete's foot containing castor oil, undecylenic acid, propyl alcohol, propylene glycol, and water from which castor is extracted with hexane.
  • the extracted castor oil has better antifungal activity than the castors extracted by high temperature and high pressure compression method. Therefore, through the excellent antifungal effect of the composition, various foot, such as athlete's foot, hand lines around the groin, nail ring or nail claws (nail nail athlete's foot), head ringworm on the head, body ringworm on the body, etc. Athlete's foot can be easily treated.
  • Example 1 is a photograph showing the results of the antifungal effect of the composition of Example 1-1 of the present invention confirmed using a paper disc diffusion method for Candida albicans .
  • Figure 2 is a graph showing the results of the antifungal effect of the composition of Example 1-1 of the present invention confirmed using a paper disc diffusion method for Candida albicans .
  • Example 1 To prepare a skin external composition for athlete's foot prevention or treatment in the same manner as in Example 1, the components of each composition was prepared with reference to the weight disclosed in Table 2 (Comparative Example 1-1 does not include undecylenic acid no pH adjustment).
  • Trichophyton rubrum (KCTC 6345), Trichophyton mentagrophytes (KCTC 6077), Microsporum canis (KCTC 6348) from the Korean Collection for Type Cultures (KCTC) 4 Candida albicans (KCTC 7965) were distributed and their inhibitory activity was assayed by paper disc diffusion method.
  • SDA Sebed dextrose agar
  • SDA Sebed dextrose agar
  • the cultured strains were inoculated into the SDB medium and incubated at 28 ° C. for 7 days (however, Candida albicans was cultured daily), and 1 ml of each culture solution and 2 ml of soft agar (0.7%) were added.
  • Example 1 of the present invention are all anti-fungal, as the low ring size for Trichophyton rubrum, Trichophyton mentagrophytes, Micros forum canis, Candida albicans is 10 mm or more. Although it was found to be remarkably excellent, the composition of Comparative Example 1 was found to have little antifungal properties because the size of the non-ring ring for each fungus is remarkably small.
  • Example 1 and Comparative Example 1 were applied to the feet of 7 athlete's foot athletes in each group, contact with water was avoided as much as possible, and each composition was recoated once a day. After 3 days from the first application, the athlete's foot treatment effect of each patient was confirmed based on the 'athlete symptom index' of Table 4 compared with the results before treatment.
  • the athletes were athletes diagnosed athlete's foot in both hospitals from January 1, 2009 to December 31, 2011, the subjects were confirmed in both men and women and the results are shown in Table 5.
  • Example 1 of the present invention is very excellent in athlete's foot treatment.
  • the therapeutic effect of the composition of Comparative Example 1-1, which does not contain undecylenic acid, and the composition of Comparative Example 1-2, which does not contain castor oil extracted with hexane was very low.
  • the therapeutic effect of the composition using castor oil was also found to be significantly different compared to the composition of Example 1.
  • even if all the castor oil extracted with undecylenic acid or hexane is included in the content range for preparing the composition of the present invention it was found that the effect is not high.
  • Comparative Examples 1-6 and Comparative Examples 1-7 are propylene glycol and propyl alcohol-free compositions, respectively, even if these components are not included, the antifungal effect was found to be somewhat low.
  • the antifungal effect of the composition of the present invention was determined to be excellent only when all were included, which is expected because propylene glycol or propyl alcohol plays a role in enhancing the skin coating effect.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The composition of the present invention relates to a composition including castor oil extracted from castor beans by using hexane, undecylenic acid, propyl alcohol, propylene glycol, and water for external use on the skin for preventing or treating athlete's foot. Among the constituent components of the composition, the castor oil extracted from castor beans using hexane exhibits better antifungal activity compared to that of castor oil extracted using a compression method at a high temperature under high pressure. Thus, through the excellent antifungal effect of the composition, various kinds of athlete's foot such as athlete's foot erupting on the hands and feet, tinea cruris around the inguinal, tinea unguium (athlete's foot on nails) erupting on the fingernails or toenails, tinea capitis erupting on the head, tinea corporis erupting on the body may be easily treated.

Description

피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 무좀 예방 또는 치료용 피부 외용제 조성물Athlete's foot skin composition containing castor oil, undecylenic acid, propyl alcohol, propylene glycol and water extracted from castor hexane
본 발명은 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 무좀 예방 또는 치료용 피부 외용제 조성물에 관한 것이다. The present invention relates to a skin external preparation composition for athlete's foot prevention or treatment containing castor oil extracted from hexane, undecylenic acid, propyl alcohol, propylene glycol and water.
무좀(tinea pedis)은 가장 흔히 관찰되는 진균 감염 증상의 하나로서, 곰팡이가 피부의 각질을 녹여 영양분으로 삼아 기생, 번식하는 피부질환이다. 이들의 원인균은 피부에 친화력을 갖는 진균류 중에서 주로 트리코피톤 루브럼(Trichophyton rubrum), 트리코피톤 멘타그로피테스(Trichophyton mentagrophytes), 마이크로스포럼 카니스(Microsporum canis), 칸디다 알비칸스(Candida albicans) 등이며, 이들이 피부의 각질에 침투하여 가려움, 발적, 염증 등의 증상을 일으킨다고 한다. 이들 진균류의 감염증이 악화되는 정도는 감염 부위의 환경, 개인적인 면역 능력에 따라 달라진다고 알려져 있다. 한편, 현대사회는 신발이나 양말들을 장시간 착용하는 생활을 주로 하는데, 상기와 같은 진균류의 감염 후, 신발, 양말 등에 의해 피부가 외부와 폐쇄된 채로 장시간 유지되면 감염 부위의 열과 습기로 인해 진균류들의 증식이 향상되고, 무좀이 발생하게 된다. Athlete's foot (tinea pedis) is one of the most common symptoms of fungal infections. It is a parasitic and multiplying skin disease in which the fungus dissolves the keratin of the skin and nourish it. Among the fungi having affinity for the skin, trichophyton rubrum , Trichophyton mentagrophytes , Microsporum canis , Candida albicans , etc. They penetrate the keratin of the skin and cause symptoms such as itching, redness, and inflammation. The exacerbation of these fungal infections is known to depend on the environment at the site of infection and the individual's ability to immunize. On the other hand, the modern society mainly wears shoes or socks for a long time. After the infection of the fungus, if the skin is kept closed for a long time by the shoes and socks, the fungus proliferates due to heat and moisture of the infected area. This improves, and athlete's foot occurs.
무좀은 곰팡이가 좋아하는 각질이 풍부하고 습하며 따뜻한 곳(발가락, 발바닥, 발톱, 손톱, 옆구리, 사타구니 주변, 살이 겹쳐지는 곳)의 신체 대부분의 부위에서 발병된다. 일반적으로 발에 생기는 것만을 무좀이라고 생각하기 쉽지만, 발과 손은 물론이고 사타구니 주변의 완선, 손톱 또는 발톱에 생기는 조갑백선(손발톱무좀), 머리에 생기는 두부백선, 몸통에 생기는 체부백선 등을 포함한다. 통계상 전체 인구의 10% 이상이 무좀으로 고생하고 있으며 20~40대에 가장 많이 발병한다. 드물게는 소아에게도 발병한다. Athlete's foot is found in most parts of the body in funky, keratin-rich, moist, warm areas (toes, soles, toenails, nails, flanks, groin, and flesh). In general, it is easy to think that only foot is the athlete's foot, but it includes not only feet and hands, but also ridges around the groin, nails or nails on the toe, nail whites on the head, and body whites on the body. do. According to statistics, more than 10% of the total population suffers from athlete's foot, most frequently in their 20s and 40s. Rarely occurs in children.
무좀은 발생 형태에 따라서, 지간형, 소수포형과 각화형으로 구분한다. 지간경 타입은 발가락 사이에서 주로 발생하는데, 이 부위가 외부와 공기가 잘 통하지 않고 습기가 높기 때문에 무좀균의 서식이 쉽기 때문이다. 지간형 무좀이 발생되면, 가려움증이 심하고, 피부가 희게 짓무르고 갈라져서 불쾌한 냄새가 많이 나고, 때로는 양쪽 발가락과 발바닥으로 퍼지기도 한다. 소수포형 타입의 무좀에서는 크기가 다양한 물집이 생기게 되고, 가려움증으로 인해 긁게 되면 살이 벗겨져서 딱지가 자주 생성되고, 여름에 땀이 많을 때 많이 악화되는 것으로 알려져있다. 각화형 타입의 무좀은 발바닥 전체에 걸쳐 각질이 두꺼워지며 굵으면 가루가 떨어지는 증상을 말하는데, 만성적인 난치성 무좀으로 발전되기가 쉽다. Athlete's foot is divided into a basal, hydrophobic, and keratinous form depending on the developmental form. The interstitial type occurs mainly between the toes, because the area is not easily communicated with the outside air and the moisture is high, so the fungus is easily inhabited. When the intercostal athlete's foot occurs, itching is severe, the skin is whitened and cracked, causing an unpleasant odor, and sometimes spreads to both toes and soles. In the athlete's foot type, blisters of various sizes are produced, and when it is scratched due to itching, the skin is peeled off frequently, and a lot of sweat is known to deteriorate a lot during the summer sweating. Athlete's foot-type athlete's foot is thickened over the entire sole of the foot and thick, which means that the powder falls. It is easy to develop into chronic refractory athlete's foot.
한편, 무좀을 제대로 치료하지 않고 방치할 경우 균이 발등이나 발톱 등 신체 다른 부위로 침투하게 되어 손발톱 무좀 등으로 발전하는데, 우리나라 전체인구의 5%, 전체 무좀환자의 20~30%가 손발톱 무좀을 앓고 있는 것으로 알려져 있다. 손발톱 무좀은 발톱이나 손톱에 곰팡이 균이 감염되어 손발톱에 두터운 각화와 색깔변화를 일으키고 진행되면 손발톱이 부스러져 변형을 일으키는 증상을 말하는데, 특히 최근에는 노령인구의 증가와 수영장이나 헬스장 찜질방등의 이용이 늘면서 무좀 진균에 노출될 가능성이 증가되어 더욱 증가하는 추세이다. On the other hand, if left untreated, fungi can penetrate into other parts of the body, such as insteps or toenails, and develop into nail footing. 5% of the entire population of Korea and 20-30% of all athlete's foot athletes It is known to suffer. Nail athlete's foot is a symptom of fungal infection of the toenails or nails, which causes thick keratinization and color change in the nails, and the nails crumble when they progress. In particular, the recent increase in the elderly population and the use of swimming pools or gym spas Increasingly, the likelihood of exposure to athlete's foot fungi increases.
이 외에, 주로 발생하는 체부백선 중의 하나 중 사타구니 완선이 있는데, 주로 고온 다습한 피부 환경, 비만, 밀착된 옷과 피부와의 마찰이 주원인으로 작용해 무좀균이 서식하기 시작하면서 발생되며 발 무좀과 동반되는 경우가 많다. 내의를 갈아입으면서 발의 무좀균이 내의에 묻어서 올라오면서 주로 발생하며, 대부분 남자에게 발생하며 음낭, 엉덩이, 대퇴부까지 번지기도 한다. 주로 습한 여름에 상태가 악화되고 건조한 겨울에는 검은 착색만 남기고 주증상은 대부분 사라진다. 거의 양쪽 사타구니에서 발생하는데 시작은 고환이 닿는 부위에서 먼저 시작해서 양쪽 사타구니에 번지면서 나타나며, 사타구니의 침범 없이 고환이나 음경 치골부위에서 붉은 각질이 시작하기도 한다. 여자보다 남자에서 사타구니 완선이 월등히 잘 생기는 이유는 남자가 여자보다 밀폐된 옷을 더 많이 입고, 고환이 있어 사타구니가 더 밀폐되고 남자의 경우 발 무좀의 빈도가 더 높기 때문이다. In addition, one of the most common baekbueum occurs in the groin completeness, mainly due to high temperature and high humidity skin conditions, obesity, close clothing and friction between the skin and the skin caused by the athlete's foot fungus is inhabited and accompanied by foot athlete's foot There are many cases. Athlete's foot athlete's foot fungus is usually buried in the inner part of the body, most often occur in men, scrotum, buttocks, thighs are also spread. The condition worsens mainly in wet summers, leaving only black pigmentation in dry winters, and most of the main symptoms disappear. It occurs almost in both groin. The onset begins at the point where the testis touches and then spreads to both groin, and red keratin may begin in the testicle or penis bone without groin invasion. The reason why groin completeness is significantly better in men than in women is because men wear more sealed clothing than women, testicles are more sealed in the groin, and men have a higher frequency of foot athlete's foot.
한편, 무좀은 발냄새와도 관련이 있다. 의학적으로 발냄새는 발바닥에 생기는 일종의 취한증(bromidrosis)으로서, 발바닥은 애크린 한선(eccrine gland)이 많이 분포되어 있어 다른 피부조직보다 땀이 많이 분비되는데, 이 때 발바닥에서 분비된 땀에 의해서 피부의 케라틴 조직이 뒤틀려지면서 세균과 진균류가 서식하게 되고, 이로 인해 발냄새가 발생한다. 이런 취한증은 발바닥에 가장 많이 발생하나 때로는 신체의 다른 부위인 간찰부 즉 살이 접히는 부위에서 발생하기도 한다. 발냄새는 주로 젊은 남자와 중년의 성인에게 많이 생기지만 통계적으로 의미있는 인종 간의 차이나 성별의 차이는 없다. 발냄새는 계절과 상관없이 발생하는데, 발바닥의 땀이 체온이 올라가서 생기는 것이 아니라 정서적 긴장감에 의해 유발되기 때문이다. 또한, 발냄새가 날 것이라는 불안이 환자들로 하여금 더 긴장하게 만들어 발냄새를 악화시키고 사회활동의 위축으로까지 이어지는 스트레스성 증상을 보이기도 한다. Athlete's foot is also associated with bad breath. Medically, foot odor is a form of bromidrosis that occurs on the soles of the feet. The soles of the feet have a lot of eccrine gland, which is more sweaty than other skin tissues. As the keratin tissue of the warp is distorted, bacteria and fungi inhabit, causing foot odor. Drunkenness most often occurs on the soles of the feet, but sometimes occurs in other parts of the body, such as the interrogator, or the fold of flesh. Foot odor is most common in young men and middle-aged adults, but there are no statistically significant race differences or gender differences. Foot odor occurs regardless of the season, because the sweat on the sole is caused by emotional tension, not due to a rise in body temperature. In addition, the anxiety of foot odor may make patients more nervous, causing stress symptoms that worsen foot odor and lead to social activity.
한편, 무좀은 제대로 뿌리 뽑지 않으면 계속 재발하는 경향이 있어 평생을 함께 살아야 하는 '반려 질병'이 되는 경우가 많다. 무좀은 보통 장마가 시작될 무렵에 갑자기 더 가려워진다. 무좀균이 가장 번식하기 쉬운 환경은 37℃의 온도, 적당한 습기, 영양분 등인데, 여름철은 이같은 조건들을 모두 갖추고 있어 여름이면 무좀균이 왕성하게 번식하고 기승을 부리게 된다. 그러나 무좀균은 겨울철에도 피부에 달라붙어 있으며, 다만 활동이 약화될 뿐 습하고 따뜻한 환경에서 왕성한 번식력을 자랑하던 균이 겨울에는 잘 번식할 수 없어 피부 속에 숨어지낸다. On the other hand, athlete's foot tends to recur if not properly rooted, so it often becomes 'companion disease' that must live together for a lifetime. Athlete's foot is suddenly itchy at the beginning of the rainy season. Athlete's most probable environment is the temperature of 37 ℃, moderate humidity, nutrients, etc., summer has all of these conditions, so the athlete's fungus multiplies and rises in summer. However, athlete's foot sticks to the skin even in winter, but the activity is weakened, but the bacteria that boasted strong breeding ability in the humid and warm environment cannot hide well in the winter and hide in the skin.
Harrison, P.V. 등(Clin. Exp. Dermatol. 17, 467, 1992)에 의하면 무좀은 어린 아이들보다는 어른들에게서 잘 나타나며, 선진국 성인 인구의 10~15%가 무좀을 갖고 있거나 감염 경험이 있다고 알려져 있다. 그리고, 무좀이라고 하면 예전에는 중년 남성에게 많은 병이었지만 근래에는 여성, 특히, 여고생 등의 젊은 여성에게도 증가하고 있는 경향이 있다. 이는 남녀노소 모두 사회활동이 활발해져 밖에서 생활하는 시간이 길어져 무좀이 번성할 환경이 많아졌기 때문이다. Harrison, P. V. (Clin. Exp. Dermatol. 17, 467, 1992) shows that athlete's foot is more common in adults than children, and 10 to 15 percent of the adult population in developed countries have athlete's foot or have been infected. Speaking of athlete's foot, it used to be a disease for middle-aged men in the past, but recently, it tends to increase in women, especially young women such as high school girls. This is because both young and old have a lot of social activities, and the time to live outside has increased and the environment for athletes to thrive.
무좀을 치료하기 위해서는 무좀 원인균을 죽이거나 균의 성장을 억제하는 방법이 고려된다. 주로 사용되는 치료제는 바르는 항진균제를 들 수 있으며, 사용하기 편리하면서도 부작용이 적기 때문에 많이 사용된다. 그러나, 바르는 치료제를 사용하는 것만으로는 완치가 어렵고, 적어도 수주 이상 도포하여야 하는 것이 일반적이다. 다음으로는 먹는 항진균제가 있는데, 상기 치료제들의 효과는 바르는 약에 비하여 좋은 편이나 간독성, 신독성 등의 부작용이 드물지 않게 발생하고 있어 투여에 주의하여야 한다. 무좀 치료시, 각질 연화제를 함께 사용하여 무좀균이 살고 있는 각질을 탈락시키거나 증상을 호전시키기 위하여 스테로이드 제제를 겸하여 사용하기도 하며, 항진균제와 살리실산 등이 처방된 외용액제, 연고, 스프레이 등이 이미 개발되어 상용화되어 있기도 하다. In order to treat athlete's foot, a method of killing athlete's foot causing bacteria or inhibiting the growth of bacteria is considered. The most commonly used therapeutics include antifungal agents, which are used because they are easy to use and have fewer side effects. However, it is difficult to cure only by using a coating agent, and it is common to apply at least several weeks. Next, there is an antifungal drug to eat, the effect of the treatments are good compared to the drug, but side effects such as hepatotoxicity, nephrotoxicity, etc. rarely occurs, so care should be taken in the administration. In the treatment of athlete's foot, it is also used as a steroid preparation to eliminate the dead skin or improve the symptoms by using the keratin softener together, and external preparations, ointments, sprays, etc. prescribed with antifungal and salicylic acid have already been developed. It is also commercialized.
시판중인 무좀약의 주요성분은 테르비나핀과 클로트리마졸 두 가지로 크게 나뉜다. 테르비나핀은 살균효과가 뛰어나 단시간에 빠른 효과를 볼 수 있는 장점이 있다. 반면 클로트리마졸은 살균보다는 균의 증식을 막아 서서히 치료하는데 초점이 맞춰져 있다. 클로트리마졸을 이용시 치료 기간이 길기는 하지만, 훼손된 피부를 복원시키는 데는 테르비나핀을 사용하는 제품에 비해 강점을 가지는 것으로 알려져 있다. 상기 약물들은 크림타입이나 연고타입으로 주로 제조되며, 하지만 각질이 심하게 일어나면서 굳은 살처럼 딱딱해지는 증상에 사용하기에 좋다. 그러나, 진물이 나는 증상의 무좀이나, 무좀과 함께 피부병이나 습진 등이 발생하면서 일어난 2차 감염, 또는, 손발톱 무좀의 경우는 상기와 같은 약물로는 잘 낫지 않는 것으로 알려져 있다. 또한, 시중에 많이 유통되는 광범위 피부질환 치료제의 성분은 무좀균을 죽이는 성분 외에도 정상적인 면역반응을 억제하는 부신 피질 호르몬제가 들어있어 논란이 있기도 하였다. There are two main components of athlete's foot medicine, terbinafine and clotrimazole. Terbinafine has excellent sterilizing effect and has the advantage of being able to see a quick effect in a short time. Clotrimazole, on the other hand, focuses on slow treatment rather than sterilization. Although treatment with clotrimazole takes a long time, it is known to have an advantage over terbinafine products for restoring damaged skin. The drugs are mainly manufactured in cream or ointment type, but they are good for use in the condition that the keratin is severe and becomes hard like a callus. However, in case of athlete's foot athlete's foot, secondary infection caused by skin disease or eczema with athlete's foot, or nail athlete's foot, it is known that it is not good for such drugs. In addition, the components of a wide range of drugs for the treatment of a wide range of skin diseases include corticosteroids that inhibit normal immune responses in addition to the components that kill athlete's foot, which has been controversial.
한편, 무좀은 대개의 경우 치료 후에 겉으로 증상이 나타나지 않다가도 재발되어 꾸준히 치료하지 않으면 완치가 어렵기에, 부작용이 없으면서도 안전성 및 무좀 치료 효과가 우수한 새로운 타입의 무좀 치료제가 요구되고 있는 실정이다.On the other hand, athlete's foot athletes are usually relapsed even after the appearance of symptoms after treatment, it is difficult to cure if not treated steadily, there is a need for a new type of athlete's foot treatment agent excellent safety and athlete's foot treatment effect without side effects.
피마자유(castor oil, 麻子油)는 피마자(Ricinus communis)의 종자를 압착하여 얻는 지방유로, 아주까리 기름이라고도 한다. 피마자유에는 리시놀레산(ricinoleic acid), 팔미트산(palmitic acid), 스테아린산(stearic acid), 리놀레산(linolenic acid), 하이드록시스테아린산(hydroxystearic acid), 트리리놀레인(trilinolein), 디리시놀레인(diricinolein), 모노리시놀레인(monoricinolein), 리시놀레산(ricinoleic acid), 운데실렌산(undecylenic acid) 등이 함유되어 있으며, 다른 지방유와 달리 알코올에 녹는 성질이 있다. 피마자유는 주로 하제(下劑)로서 복용하기도 하고 살진균제로도 이용되기도 한다. 화상치료 효과가 있으며, 탁월한 해열효과를 갖는다. 또한, 중이염에서 염증으로 인한 고름을 억제하는 효과가 뛰어나고, 늑막염, 복막염, 복수, 신장염, 각기병 등에도 치료효과가 있는 것으로 알려져 있다. 또한 불포화 지방산을 다량 함유하고 있어 실온에서는 굳지 않아, 윤활유, 전기절연용, 인조피혁, 타이프라이터 잉크 등으로 사용된다. 피마자유는 종자 속에 약 45% 함유되어 있다. 피마자의 종자에는 독성이 있지만, 압착하여 얻은 기름에는 없으며, 독성은 짜고 남은 찌꺼기에 남는다. 피마자유는 담황색으로 약간 점성이 있고, 간유(肝油)처럼 특이한 냄새가 강한데, 대부분 다른 지방유와 달리 알코올에 녹는다. 피마자유를 하제로 이용할 시에는 1회당 10~20㎖를 복용하며, 피마자유를 마셨다고 해서 복통을 일으키는 일은 거의 없다. 피마자유는 냄새·맛·뒷맛이 모두 나쁘고 복용하기 어렵기 때문에 보통 오렌지유·박하유 등을 각 0.5% 가하여 가향(加香) 피마자유로서 사용한다. 또한 의약품 외에도 윤활유·로드유 제조용, 포마드·전기절연용·인조피혁·타이프라이터잉크·브레이크 오일의 제조, 카본지(紙)·구두약 등의 원료나 특수한 도료(塗料)의 원료유로도 사용된다.Castor oil (castor oil) is a fatty oil obtained by squeezing the seeds of Ricinus communis , also known as castor oil. Castor oil contains ricinoleic acid, palmitic acid, stearic acid, linolenic acid, hydroxystearic acid, trilinolein, and diricinoleine. (diricinolein), monooricinolein (monoricinolein), ricinoleic acid (ricinoleic acid), undecylenic acid (undecylenic acid) is contained, unlike other fatty oils are soluble in alcohol. Castor oil is often taken as a laxative or as a fungicide. It has a burn treatment effect and an excellent antipyretic effect. In addition, it is known to have an excellent effect of suppressing pus due to inflammation in otitis media, and also has a therapeutic effect on pleurisy, peritonitis, ascites, nephritis, keratitis, and the like. In addition, it contains a large amount of unsaturated fatty acid and does not harden at room temperature. Therefore, it is used as lubricating oil, electric insulation, artificial leather, typewriter ink and the like. Castor oil is present in about 45% of the seeds. The seed of the castor is toxic, but not in the oil obtained by pressing, and the toxic remains salty and leftover. Castor oil is pale yellow and slightly viscous and has a peculiar smell like cod liver oil. Unlike most other fatty oils, it is soluble in alcohol. When castor oil is used as a laxative, take 10-20ml per dose. Drinking castor oil rarely causes abdominal pain. Castor oil has a bad smell, taste, and aftertaste, and is difficult to take. Therefore, orange oil and peppermint oil are added 0.5% each and used as flavored castor oil. In addition to pharmaceuticals, it is also used as a raw material for lubricating oil, rod oil, pomade, electrical insulation, artificial leather, typewriter ink, brake oil, carbon paper, oral medicine, and special paints.
운데실렌산(undecylenic acid)은 피마자유의 활성 화합물로서, 항균, 소취, 살진균 작용이 있는 것으로 알려져 있는 물질이다. Undecylenic acid is an active compound of castor oil and is known to have antibacterial, deodorant and fungicidal action.
한편, 본 발명자들은 무좀 치료제를 연구하던 중 헥산을 이용하여 추출한 피마자 기름과 운데실렌산을 함유하는 조성물이 트리코피톤 루브럼(Trichophyton rubrum, KCTC 6345), 트리코피톤 멘타그로피테스(Trichophyton mentagrophytes, KCTC 6077), 마이크로스포럼 카니스(Microsporum canis, KCTC 6348), 칸디다 알비칸스(Candida albicans, KCTC 7965) 등에 관한 항진균 효과가 우수함을 확인함으로서 본 발명을 완성할 수 있었다. On the other hand, the inventors of the present invention while studying the athlete's foot treatment composition containing castor oil and undecylenic acid extracted using hexane is Trichophyton rubrum ( KCTC 6345), Trichophyton mentagrophytes (KCTC) 6077), Microsporum canis (KCTC 6348), Candida albicans ( Candida albicans , KCTC 7965) by confirming the excellent antifungal effect was able to complete the present invention.
한국공개특허 제2006-0010742호 및 미국등록특허 제7186416호에는 운데실렌산이 무좀 치료제로서 사용될 수 있고, 한국등록특허 제500577호, 미국등록특허 제7186416호에는 피마자유가 무좀 치료용 양말의 치료약제 구성성분으로 사용될 수 있음이 개시되어 있기는 하지만, 운데실렌산과 피마자유를 모두 포함하거나, 헥산을 이용하여 추출한 피마자유가 포함된 무좀 치료용 피부 외용제 조성물에 관해서는 전혀 확인되지 않았다. In Korean Patent Laid-Open No. 2006-0010742 and US Patent No. 7186416, undecylenic acid may be used as an athlete's foot therapeutic agent, and Korean Patent No. 500577 and US Patent No. 7186416 castor oil may be used as a therapeutic agent for treating athlete's foot athlete's foot. Although it is disclosed that it can be used as a component, it has not been confirmed at all about the external skin composition for athlete's foot treatment containing undecylenic acid and castor oil, or castor oil extracted using hexane.
본 발명의 목적은 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 무좀 예방 또는 치료용 피부 외용제 조성물을 제공하는 데에 있다. An object of the present invention is to provide a composition for external athlete's foot for preventing or treating athlete's foot, which contains castor oil, undecylenic acid, propyl alcohol, propylene glycol and water extracted from castor hexane.
본 발명은 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 무좀 예방 또는 치료용 피부 외용제 조성물에 관한 것이다. The present invention relates to a skin external preparation composition for athlete's foot prevention or treatment containing castor oil extracted from hexane, undecylenic acid, propyl alcohol, propylene glycol and water.
상기 무좀 예방 또는 치료용 피부 외용제 조성물은, 피마자를 헥산으로 추출한 피마자유 0.5~2 중량%, 운데실렌산 7~11 중량%, 프로필알코올 30~50 중량%, 프로필렌글리콜 15~35 중량% 및 물 15~35 중량%를 함유할 수 있다. The skin external preparation composition for athlete's foot prevention or treatment, castor oil extracted from hexane 0.5 ~ 2% by weight, undecylenic acid 7 ~ 11% by weight, propyl alcohol 30 ~ 50% by weight, propylene glycol 15 ~ 35% by weight and water It may contain 15 to 35% by weight.
상기 무좀 예방 또는 치료용 피부 외용제 조성물은 트리에탄올아민 용액을 이용하여 pH가 6.0~6.5로 조절된 조성물일 수 있다.The skin external preparation composition for preventing or treating athlete's foot may be a composition having a pH of 6.0 to 6.5 using a triethanolamine solution.
또한, 상기 무좀은 트리코피톤 루브럼(Trichophyton rubrum), 트리코피톤 멘타그로피테스(Trichophyton mentagrophytes), 마이크로스포럼 카니스(Microsporum canis) 및 칸디다 알비칸스(Candida albicans)로 이루어진 군 중에서 선택되는 진균류로부터 유도되는 질환인 것을 특징으로 한다.In addition, the athlete's foot is from a fungus selected from the group consisting of Trichophyton rubrum , Trichophyton mentagrophytes , Microsporum canis and Candida albicans It is characterized in that the disease is induced.
상기 조성물은, 바람직하게는, The composition is preferably,
(1단계) 피마자(Ricinus communis의 씨앗) 분쇄물을 노르말 헥산과 혼합하여 15~27℃에서 교반하는 단계;(Step 1) Mixing a castor (seeds of Ricinus communis ) ground with normal hexane and stirring at 15 ~ 27 ℃;
(2단계) 상기 교반물에서 고형분을 제거하고 남은 추출액을 중탕을 이용한 감압농축법으로 노르말 헥산을 분리한 후 남은 피마자유를 수거하는 단계; 및,(Step 2) collecting the remaining castor oil after removing the solid content from the stirring and separating the remaining hexane by the concentrated vacuum method using a heated bath; And,
(3단계) 상기 피마자를 헥산으로 추출한 피마자유 0.5~2 중량%, 운데실렌산 7~11 중량%, 프로필알코올 30~50 중량%, 프로필렌글리콜 15~35 중량% 및 물 15~35 중량%를 혼합하고 교반하는 단계;(Step 3) 0.5 to 2% by weight of castor oil extracted from the hexane, 7 to 11% by weight undecylene acid, 30 to 50% by weight of propyl alcohol, 15 to 35% by weight of propylene glycol and 15 to 35% by weight of water Mixing and stirring;
를 통해 제조될 수 있다. It can be prepared through.
또한, 상기 3단계에서 혼합물의 교반 시, 트리에탄올아민 용액을 이용하여 pH를 6.0~6.5로 조절할 수 있다. In addition, when the mixture is stirred in the third step, it is possible to adjust the pH to 6.0 ~ 6.5 using a triethanolamine solution.
이하, 본 발명을 자세하게 설명한다.Hereinafter, the present invention will be described in detail.
상기 피마자 분쇄물을 노르말 헥산으로 추출하여 피마자 분쇄물 중량의 25~45 중량%에 해당되는 피마자유를 수득할 수 있다. The castor pulverized product may be extracted with normal hexane to obtain castor oil corresponding to 25 to 45 wt% of the weight of the castor pulverized product.
피마자 분쇄물에 노르말 헥산은 피마자 중량대비 2~20배(w/v)가 첨가될 수 있다. Normal hexane may be added 2 to 20 times (w / v) of the weight of the castor.
이 때, 상기 3단계의 혼합물은 트리에탄올아민 용액을 첨가함으로써 전체 조성물이 맑고 투명한 상태의 용액 상태로 골고루 혼합된다. At this time, the mixture of the three steps is mixed evenly in the solution state of the clear and transparent state by adding the triethanolamine solution.
이 때, 트리에탄올아민은 조성물의 각 구성성분의 혼합을 위한 중화제로서 사용되며, 이 외에도, 조성물 내에서 계면활성제와 세정제 및 방충제 역할을 한다.At this time, triethanolamine is used as a neutralizing agent for the mixing of each component of the composition, in addition, it serves as a surfactant, detergent and insect repellent in the composition.
본 발명의 조성물은 피부외용제로서 사용되기 때문에 눈 주위처럼 자극이 약한 곳에 도포하는 것은 피하는 것이 좋다. Since the composition of the present invention is used as an external preparation for skin, it is better to avoid the application to a weak spot such as around the eye.
본 발명의 조성물은 무좀과 같은 피부 진균증의 치료제로 사용될 수 있으며, 주로, 액상 타입의 피부 도포제로 사용될 수 있으며, 스프레이제, 연고제, 크림제, 로션제, 패치제 등으로 가공되어 사용될 수도 있다. 또한, 본 발명의 조성물은 세정제, 소독제 등의 첨가제로도 사용될 수 있다. The composition of the present invention can be used as a therapeutic agent for skin fungus, such as athlete's foot, mainly used as a liquid type skin coating, and may be processed and used in sprays, ointments, creams, lotions, patches. In addition, the composition of the present invention can also be used as additives such as cleaning agents, disinfectants.
또한 본 발명의 조성물은 제제 및 사용방법에 따라 생리약학적으로 허용가능한 담체를 더욱 포함할 수 있으며, 무좀 예방 또는 치료용 피부 외용제 조성물 전체의 1.0~99.9 중량%로 포함될 수 있다. 상기 조성물의 투여량은 무좀 증상의 중한 정도 및 환자의 건강상태에 따라 조절하는 것이 바람직하다.In addition, the composition of the present invention may further include a physiologically acceptable carrier according to the formulation and the method of use, it may be included in 1.0 to 99.9% by weight of the total external skin composition for athlete's foot prevention or treatment. The dosage of the composition is preferably adjusted according to the severity of athlete's foot symptoms and the health of the patient.
본 발명의 조성물은 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 무좀 예방 또는 치료용 피부 외용제 조성물에 관한 것으로서, 상기 조성물의 구성성분 중, 피마자를 헥산으로 추출한 피마자유는 고온고압의 압착방법을 이용하여 추출된 피마자에 비해 항진균 활성이 우수하다. 따라서, 상기 조성물의 우수한 항진균 효과를 통해 발과 손에 발생하는 무좀, 사타구니 주변의 완선, 손톱 또는 발톱에 생기는 조갑백선(손발톱무좀), 머리에 생기는 두부백선, 몸통에 생기는 체부백선 등의 각종 다양한 무좀을 용이하게 치료할 수 있다. The composition of the present invention relates to a composition for external athlete's foot for preventing or treating athlete's foot containing castor oil, undecylenic acid, propyl alcohol, propylene glycol, and water from which castor is extracted with hexane. The extracted castor oil has better antifungal activity than the castors extracted by high temperature and high pressure compression method. Therefore, through the excellent antifungal effect of the composition, various foot, such as athlete's foot, hand lines around the groin, nail ring or nail claws (nail nail athlete's foot), head ringworm on the head, body ringworm on the body, etc. Athlete's foot can be easily treated.
도 1은 본 발명 실시예 1-1의 조성물의 항진균 효과를 칸디다 알비칸스(Candida albicans)에 대한 여지확산법(paper disc diffusion method)을 이용하여 확인한 결과를 나타내는 사진이다. 1 is a photograph showing the results of the antifungal effect of the composition of Example 1-1 of the present invention confirmed using a paper disc diffusion method for Candida albicans .
도 2는 본 발명 실시예 1-1의 조성물의 항진균 효과를 칸디다 알비칸스(Candida albicans)에 대한 여지확산법(paper disc diffusion method)을 이용하여 확인한 결과를 나타내는 그래프이다. Figure 2 is a graph showing the results of the antifungal effect of the composition of Example 1-1 of the present invention confirmed using a paper disc diffusion method for Candida albicans .
이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지기 위해, 또한 당업자에게 본 발명의 사상이 충분히 전달될 수 있기 위해 제공되는 것이다.Hereinafter, a preferred embodiment of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, the information provided herein is provided to be thorough and complete, and also to fully convey the spirit of the present invention to those skilled in the art.
<실시예 1. 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 무좀 예방 또는 치료용 피부 외용제 조성물의 제조><Example 1. Preparation of athlete's foot external preparation composition for athlete's foot prevention or treatment containing castor oil, undecylenic acid, propyl alcohol, propylene glycol and water extracted with hexane>
피마자(Ricinus communis의 씨앗) 1kg을 100mesh 크기로 분쇄하여 노르말 헥산 10ℓ과 혼합하고 25℃ 실온에서 교반하였다. 이 후, 씨앗 고형분을 제거하고 남은 추출액을 중탕법을 이용한 감압농축을 하여 노르말 헥산을 분리하였으며(분리된 기체상태의 노르말 헥산은 응축시켜 회수함), 노르말 헥산이 모두 분리된 피마자유 307g을 별도로 수거하였다.1 kg of castor (seed of Ricinus communis ) was ground to a size of 100 mesh, mixed with 10 L of normal hexane, and stirred at 25 ° C. room temperature. After that, the seed solids were removed, and the remaining extract was concentrated under reduced pressure using a water bath to separate normal hexane (condensed and recovered as a separated gaseous normal hexane). Collected.
이 후, 상기 헥산을 이용하여 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 하기 표 1의 조건으로 혼합하고 교반하면서, 트리에탄올아민 용액으로 상기 혼합액의 pH를 6.0~6.5로 조절하여 본 발명의 무좀 치료용 피부 외용제 조성물을 제조하였다.Thereafter, castor oil, undecylenic acid, propyl alcohol, propylene glycol and water extracted using the hexane were mixed and stirred under the conditions shown in Table 1 below, and the pH of the mixed solution was adjusted to 6.0 to 6.5 with a triethanolamine solution. A skin external composition for treating athlete's foot was prepared.
표 1
조건 중량(g)
헥산으로 추출한 피마자유 운데실렌산 프로필알코올 프로필렌글리콜
실시예 1-1 10 90 400 250 250
실시예 1-2 5 95 300 300 300
실시예 1-3 15 85 500 200 200
실시예 1-4 10 70 420 150 350
실시예 1-5 10 110 380 350 150
Table 1
Condition Weight (g)
Castor oil extracted with hexane Undecylenic acid Propyl Alcohol Propylene glycol water
Example 1-1 10 90 400 250 250
Example 1-2 5 95 300 300 300
Example 1-3 15 85 500 200 200
Example 1-4 10 70 420 150 350
Example 1-5 10 110 380 350 150
<비교예 1. 비교대상 무좀 예방 또는 치료용 피부 외용제 조성물의 제조><Comparative Example 1. Preparation of skin external preparation composition for preventing or treating athlete's foot>
상기 실시예 1과 동일한 방법으로 무좀 예방 또는 치료용 피부 외용제 조성물을 제조하되, 각 조성물의 구성성분은 하기 표 2에 개시된 중량을 참고하여 제조하였다(운데실렌산이 포함되지 않는 비교예 1-1은 pH 조절을 하지 않음). To prepare a skin external composition for athlete's foot prevention or treatment in the same manner as in Example 1, the components of each composition was prepared with reference to the weight disclosed in Table 2 (Comparative Example 1-1 does not include undecylenic acid no pH adjustment).
표 2
조건 중량(g)
헥산으로 추출한 피마자유 압착 피마자유 운데실렌산 프로필알코올 프로필렌글리콜
비교예 1-1 10 0 0 400 295 295
비교예 1-2 0 0 100 400 250 250
비교예 1-3 0 10 90 400 250 250
비교예 1-4 25 0 50 425 250 250
비교예 1-5 3 0 150 400 223 224
비교예 1-6 10 0 90 650 0 250
비교예 1-7 10 0 90 0 650 250
TABLE 2
Condition Weight (g)
Castor oil extracted with hexane Crimped Castor Oil Undecylenic acid Propyl Alcohol Propylene glycol water
Comparative Example 1-1 10 0 0 400 295 295
Comparative Example 1-2 0 0 100 400 250 250
Comparative Example 1-3 0 10 90 400 250 250
Comparative Example 1-4 25 0 50 425 250 250
Comparative Example 1-5 3 0 150 400 223 224
Comparative Example 1-6 10 0 90 650 0 250
Comparative Example 1-7 10 0 90 0 650 250
<실험예 1. 항진균 효과 확인>Experimental Example 1. Confirmation of antifungal effect
한국 유전자은행(Korean Collection for Type Cultures, KCTC)으로부터 트리코피톤 루브럼(Trichophyton rubrum, KCTC 6345), 트리코피톤 멘타그로피테스(Trichophyton mentagrophytes, KCTC 6077), 마이크로스포럼 카니스(Microsporum canis, KCTC 6348), 칸디다 알비칸스(Candida albicans, KCTC 7965) 4종을 분양받으며 이들의 생육저해활성은 여지확산법(paper disc diffusion method)으로 검정하였다. Trichophyton rubrum ( KCTC 6345), Trichophyton mentagrophytes (KCTC 6077), Microsporum canis (KCTC 6348) from the Korean Collection for Type Cultures (KCTC) 4 Candida albicans (KCTC 7965) were distributed and their inhibitory activity was assayed by paper disc diffusion method.
먼저 40g의 덱스트로스(dextrose) 및 10g의 펩톤(peptone)을 혼합하여 총 1ℓ가 되도록 물을 첨가하여 가열 및 멸균하여 SDB(Saboraud dextrose broth) 배지를 준비하였고, 동일한 조성에 15g의 아가(agar)를 추가하여(40g 덱스트로스, 10g 펩톤, 아가 15g, 물 혼합하여 총 1ℓ) SDA(Saboraud dextrose agar)를 준비하였다. 이 후, 분양받은 균주를 상기 SDB 배지에 접종하여 28℃에서 7일간 호기배양하였고(단, 칸디다 알비칸스는 1일 배양), 각 배양액 1㎖과 연우무(soft agar, 0.7%) 2㎖을 골고루 혼합하여 SDA 배지에 도말하였다. SDA 배지에 접종한 후에는 실시예 1 및 비교예 1의 조성물을 10, 20 및 50㎕씩 처리한 여지(paper disc)를 각 균이 접종된 배지에 올려놓고 28℃에서 14일간 호기배양하였다(단, 칸디다 알비칸스는 1일 배양). 항진균 활성은 여지 주위에 형성된 생육저해환(clear zone)의 크기를 보고 확인하였으며, 이에 대한 결과는 하기 표 3에 나타내었다. 이 때, 각 조성물로 인해 생육저해환의 크기가 10㎜ 이상으로 나타난 경우를 항진균 활성이 있는 것으로 판단하였다.First, 40 g of dextrose and 10 g of peptone were mixed to add 1 L of water and heated and sterilized to prepare SDB (Saboraud dextrose broth) medium, and 15 g of agar (agar) in the same composition. SDA (Saboraud dextrose agar) was prepared by adding (40 g dextrose, 10 g peptone, agar 15 g, water 1 g in total). Subsequently, the cultured strains were inoculated into the SDB medium and incubated at 28 ° C. for 7 days (however, Candida albicans was cultured daily), and 1 ml of each culture solution and 2 ml of soft agar (0.7%) were added. Mix evenly and spread on SDA medium. After inoculation in SDA medium, paper discs treated with 10, 20 and 50 μl of the compositions of Example 1 and Comparative Example 1 were placed on a medium inoculated with each bacterium and incubated for 14 days at 28 ° C. ( However, Candida albicans is cultured daily). Antifungal activity was confirmed by looking at the size of the clear zone formed around the margin, and the results are shown in Table 3 below. At this time, the size of the growth inhibition ring due to each composition was determined to have an antifungal activity in 10mm or more.
표 3
조건 paper disc에 도포된 용량(㎕) 저지환의 크기 (㎜)
트리코피톤 루브럼 트리코피톤 멘타그로피테스 마이크로스포럼 카니스 칸디다알비칸스
실시예 1-1 10 ++++ ++ ++ ++
20 +++++ +++ +++ ++
50 ++++++ +++++ ++++ ++++
실시예 1-2 10 +++ ++ ++ ++++
20 ++++ ++ ++++ +++++
50 +++++ ++++ ++++ +++++
실시예 1-3 10 +++ ++ ++ +++
20 ++++ +++ ++ ++++
50 +++++ +++ ++++ +++++
실시예 1-4 10 +++ +++ ++ +++
20 +++ ++++ ++ +++
50 ++++ ++++ ++++ ++++
실시예 1-5 10 ++ ++ +++ ++
20 ++++ +++ ++++ +++
50 ++++ ++++ ++++ +++++
비교예 1-1 10 + + + +
20 + + + +
50 ++ + + +
비교예 1-2 10 + + + +
20 + + + +
50 + + + +
비교예 1-3 10 + + + +
20 + + + +
50 + ++ + ++
비교예 1-4 10 + + + +
20 ++ + + +
50 +++ ++ ++ +
비교예 1-5 10 + + + +
20 + ++ + +
50 ++ ++ +++ ++
10㎜ 이하 : +, 10~14㎜ : ++, 15~19㎜ : +++, 20~24 : ++++, 25~30 : +++++, 30㎜ 이상 : ++++++
TABLE 3
Condition Volume applied to paper disc (μl) Size of low ring (mm)
Tricophyton rubrum Trichophyton Mentagrophytes Micros Forum Canis Candida albicans
Example 1-1 10 ++++ ++ ++ ++
20 +++++ +++ +++ ++
50 ++++++ +++++ ++++ ++++
Example 1-2 10 +++ ++ ++ ++++
20 ++++ ++ ++++ +++++
50 +++++ ++++ ++++ +++++
Example 1-3 10 +++ ++ ++ +++
20 ++++ +++ ++ ++++
50 +++++ +++ ++++ +++++
Example 1-4 10 +++ +++ ++ +++
20 +++ ++++ ++ +++
50 ++++ ++++ ++++ ++++
Example 1-5 10 ++ ++ +++ ++
20 ++++ +++ ++++ +++
50 ++++ ++++ ++++ +++++
Comparative Example 1-1 10 + + + +
20 + + + +
50 ++ + + +
Comparative Example 1-2 10 + + + +
20 + + + +
50 + + + +
Comparative Example 1-3 10 + + + +
20 + + + +
50 + ++ + ++
Comparative Example 1-4 10 + + + +
20 ++ + + +
50 +++ ++ ++ +
Comparative Example 1-5 10 + + + +
20 + ++ + +
50 ++ ++ +++ ++
10 mm or less: +, 10-14 mm: ++, 15-19 mm: +++, 20-24: ++++, 25-30: +++++, 30 mm or more: ++++ ++
표 3을 참고하면, 본 발명의 실시예 1의 조성물들은 모두 트리코피톤 루브럼, 트리코피톤 멘타그로피테스, 마이크로스포럼 카니스, 칸디다 알비칸스에 대한 저지환 크기가 10㎜ 이상으로써, 항진균성이 현저하게 우수한 것으로 나타났으나, 비교예 1의 조성물은 각 진균에 대한 저지환 크기가 이에 비해 현저하게 작아 항진균성이 거의 없는 것으로 나타났다. Referring to Table 3, the compositions of Example 1 of the present invention are all anti-fungal, as the low ring size for Trichophyton rubrum, Trichophyton mentagrophytes, Microsforum canis, Candida albicans is 10 mm or more. Although it was found to be remarkably excellent, the composition of Comparative Example 1 was found to have little antifungal properties because the size of the non-ring ring for each fungus is remarkably small.
<실험예 2. 무좀 치료 효과 확인> Experimental Example 2 Checking the Athlete's Foot Treatment Effect
상기 실시예 1 및 비교예 1의 조성물을 각 군별로 7명의 무좀을 앓고 있는 환자들의 발에 바르게 한 후, 물의 접촉을 최대한 피하게 하였으며, 하루에 1회식 각 조성물을 재도포하였다. 처음 도포한 날로부터 3일 후, 각 환자들의 무좀 치료 효과를 치료 전의 결과와 비교한 표 4의 ‘무좀 증상 지수’를 기준으로 확인하였다. After the compositions of Example 1 and Comparative Example 1 were applied to the feet of 7 athlete's foot athletes in each group, contact with water was avoided as much as possible, and each composition was recoated once a day. After 3 days from the first application, the athlete's foot treatment effect of each patient was confirmed based on the 'athlete symptom index' of Table 4 compared with the results before treatment.
상기 무좀 환자들은 2009년 1월 1일부터 2011년 12월 31일까지 양방병원에서 무좀 진단을 받은 환자들이었으며, 남녀노소를 모두 포함하는 사람들을 대상으로 확인하였고 결과는 표 5에 나타내었다. The athletes were athletes diagnosed athlete's foot in both hospitals from January 1, 2009 to December 31, 2011, the subjects were confirmed in both men and women and the results are shown in Table 5.
표 4
무좀 증상 지수
1점: 발냄새, 각질생성, 가려움증이 심함, 치료 전과 변화 없음/2점: 치료 전에 비해 발냄새, 각질생성, 가려움증이 20% 정도 줄어듦/3점: 치료 전에 비해 발냄새, 각질생성, 가려움증이 50% 정도 줄어듦/4점: 치료 전에 비해 발냄새, 각질생성, 가려움증이 80% 정도 줄어듦/5점: 치료 전에 비해 발냄새, 각질생성, 가려움증이 완전히 사라짐
Table 4
Athlete's foot symptom index
1 point: foot odor, keratinization, itching severe, no change before and after treatment / 2 points: foot odor, keratinization and itching are reduced by 20% compared to before treatment / 3 point: foot odor, keratinization and itching compared to before treatment Reduced by 50% / 4 points: Foot odor, keratinization and itching are reduced by 80% compared to before treatment / 5 points: Foot odor, keratinization and itching disappear completely
표 5
조건 무좀 증상 지수 평균값
실시예 1-1 4.7
실시예 1-2 4.6
실시예 1-3 4.5
실시예 1-4 4.3
실시예 1-5 4.1
비교예 1-1 1.7
비교예 1-2 1.3
비교예 1-3 2.2
비교예 1-4 2.5
비교예 1-5 2.6
비교예 1-6 3.2
비교예 1-7 3.3
대조군(비도포군) 1.0
Table 5
Condition Athlete's foot symptoms index mean
Example 1-1 4.7
Example 1-2 4.6
Example 1-3 4.5
Example 1-4 4.3
Example 1-5 4.1
Comparative Example 1-1 1.7
Comparative Example 1-2 1.3
Comparative Example 1-3 2.2
Comparative Example 1-4 2.5
Comparative Example 1-5 2.6
Comparative Example 1-6 3.2
Comparative Example 1-7 3.3
Control group 1.0
상기 결과를 참고하면, 본 발명의 실시예 1의 조성물이 무좀 치료 효과가 매우 우수한 것으로 확인되었다. 한편, 운데실렌산이 포함되지 않는 비교예 1-1의 조성물, 헥산으로 추출한 피마자유가 포함되지 않는 비교예 1-2의 조성물의 치료효과는 매우 낮았으며, 헥산으로 추출한 피마자유 대신 일반적으로 사용하는 압착 피마자유를 사용한 조성물의 치료효과도 실시예 1의 조성물에 비해 현저하게 차이가 나는 것으로 나타났다. 또한, 운데실렌산이나 헥산으로 추출한 피마자유가 모두 포함된다 할지라도 본 발명의 조성물을 제조하는 함량 범위를 벗어나게 되면, 그 효과가 역시 높지 않은 것을 알 수 있었다. Referring to the results, it was confirmed that the composition of Example 1 of the present invention is very excellent in athlete's foot treatment. On the other hand, the therapeutic effect of the composition of Comparative Example 1-1, which does not contain undecylenic acid, and the composition of Comparative Example 1-2, which does not contain castor oil extracted with hexane, was very low. The therapeutic effect of the composition using castor oil was also found to be significantly different compared to the composition of Example 1. In addition, even if all the castor oil extracted with undecylenic acid or hexane is included in the content range for preparing the composition of the present invention, it was found that the effect is not high.
또한, 비교예 1-6 및 비교예 1-7은 각각 프로필렌글리콜, 프로필알코올이 없는 조성물인데, 이 성분들이 포함되지 않아도 항진균효과가 다소 낮은 것으로 나타났으며, 실시예 1처럼 이 2가지 조성물이 모두 포함되어야만 본 발명의 조성물의 항진균 효과가 우수한 것으로 판단되었는데, 이는 프로필렌글리콜이나 프로필알코올이 피부도포효과를 증진시켜주는 역할을 하고 있기 때문으로 예상되었다. In addition, Comparative Examples 1-6 and Comparative Examples 1-7 are propylene glycol and propyl alcohol-free compositions, respectively, even if these components are not included, the antifungal effect was found to be somewhat low. The antifungal effect of the composition of the present invention was determined to be excellent only when all were included, which is expected because propylene glycol or propyl alcohol plays a role in enhancing the skin coating effect.

Claims (5)

  1. 피마자를 헥산으로 추출한 피마자유 0.5~2 중량%, 운데실렌산 7~11 중량%, 프로필알코올 30~50 중량%, 프로필렌글리콜 15~35 중량% 및 물 15~35 중량%를 함유하는 것을 특징으로는 무좀 예방 또는 치료용 피부 외용제 조성물.Castor oil extracted with hexane, containing 0.5 to 2% by weight of castor oil, 7 to 11% by weight of undecylenic acid, 30 to 50% by weight of propyl alcohol, 15 to 35% by weight of propylene glycol and 15 to 35% by weight of water. The external preparation composition for athlete's foot prevention or treatment.
  2. 제1항에 있어서,The method of claim 1,
    상기 조성물은 트리에탄올아민 용액을 이용하여 pH가 6.0~6.5로 조절되는 것을 특징으로 하는 무좀 예방 또는 치료용 피부 외용제 조성물.The composition is a skin external composition for athlete's foot prevention or treatment, characterized in that the pH is adjusted to 6.0 ~ 6.5 by using a triethanolamine solution.
  3. 제1항에 있어서, The method of claim 1,
    상기 무좀은 트리코피톤 루브럼(Trichophyton rubrum), 트리코피톤 멘타그로피테스(Trichophyton mentagrophytes), 마이크로스포럼 카니스(Microsporum canis) 및 칸디다 알비칸스(Candida albicans)로 이루어진 군 중에서 선택되는 진균류로부터 유도되는 질환인 것을 특징으로 하는 무좀 예방 또는 치료용 피부 외용제 조성물.The athlete's foot is derived from a fungus selected from the group consisting of Trichophyton rubrum , Trichophyton mentagrophytes , Microsporum canis and Candida albicans . Athlete's foot external composition for athlete's foot, characterized in that the disease.
  4. (1단계) 피마자 분쇄물을 노르말 헥산과 혼합하여 15~27℃에서 교반하는 단계;(Step 1) mixing the castor pulverized product with normal hexane and stirring at 15 ~ 27 ℃;
    (2단계) 상기 교반물에서 고형분을 제거하고 남은 추출액을 중탕을 이용한 감압농축법으로 노르말 헥산을 분리한 후 남은 피마자유를 수거하는 단계; 및,(Step 2) collecting the remaining castor oil after removing the solid content from the stirring and separating the remaining hexane by the concentrated vacuum method using a heated bath; And,
    (3단계) 상기 피마자를 헥산으로 추출한 피마자유 0.5~2 중량%, 운데실렌산 7~11 중량%, 프로필알코올 30~50 중량%, 프로필렌글리콜 15~35 중량% 및 물 15~35 중량%를 혼합하고 교반하는 단계;(Step 3) 0.5 to 2% by weight of castor oil extracted from the hexane, 7 to 11% by weight undecylene acid, 30 to 50% by weight of propyl alcohol, 15 to 35% by weight of propylene glycol and 15 to 35% by weight of water Mixing and stirring;
    를 통해 제조되는 것을 특징으로 하는 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 조성물의 제조 방법. Method of producing a composition containing castor oil, undecylenic acid, propyl alcohol, propylene glycol, and water, which is cast through hexane, characterized in that it is prepared through.
  5. 제4항에 있어서,The method of claim 4, wherein
    상기 3단계에서 혼합물의 교반 시, 트리에탄올아민 용액을 이용하여 pH를 6.0~6.5로 조절하는 것을 특징으로 하는 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 조성물의 제조 방법. When the mixture is stirred in step 3, the composition containing castor oil, undecylenic acid, propyl alcohol, propylene glycol, and water extracted with castor is characterized in that the pH is adjusted to 6.0 to 6.5 using a triethanolamine solution. Method of preparation.
PCT/KR2013/010516 2012-12-31 2013-11-19 Composition including castor oil extracted from castor beans using hexane, undecylenic acid, propyl alcohol, propylene glycol, and water for external use on skin for preventing or treating athlete's foot WO2014104577A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2012-0158436 2012-12-31
KR1020120158436A KR101281470B1 (en) 2012-12-31 2012-12-31 Compositions for skin external comprising castor oil extracted hexane, undecylenic acid, propyl alcohol, propylene glycol and water for prevention or treatment of tinea pedis

Publications (1)

Publication Number Publication Date
WO2014104577A1 true WO2014104577A1 (en) 2014-07-03

Family

ID=48996415

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/010516 WO2014104577A1 (en) 2012-12-31 2013-11-19 Composition including castor oil extracted from castor beans using hexane, undecylenic acid, propyl alcohol, propylene glycol, and water for external use on skin for preventing or treating athlete's foot

Country Status (2)

Country Link
KR (1) KR101281470B1 (en)
WO (1) WO2014104577A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104998007A (en) * 2015-07-21 2015-10-28 卢秀花 Traditional Chinese medicine fumigation lotion for treating genital candida

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106163511A (en) * 2014-01-24 2016-11-23 国立大学法人京都大学 Antiinflammatory containing rare fatty acid
KR101575603B1 (en) 2014-07-15 2015-12-14 이은지 Pharmaceutical composition having antibacterial and antifungal activity and Ladies genital area cleanser composition containing the pharmaceutical composition for preventing and treating vaginitis
CN104997918A (en) * 2015-07-17 2015-10-28 柳培健 Foot tinea treating traditional Chinese medicine composition
CN104997905B (en) * 2015-07-22 2018-03-23 唐玲 A kind of Chinese medicine external use lotion for treating pruitus and preparation method thereof
CN105343716A (en) * 2015-11-28 2016-02-24 史克勇 Medicine for treating tinea pedis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010042324A (en) * 1998-03-31 2001-05-25 차알스 제이. 메츠 An acidified composition for topical treatment of nail and skin conditions
KR20040090045A (en) * 2003-04-16 2004-10-22 바이오존 주식회사 Antimicrobial composition comprising grape fruit seed extract, sodium bicarbonate, glycine, and undecylenic acid (or its Na salt) and the preparation method thereof
KR20110123739A (en) * 2009-01-08 2011-11-15 알러간, 인코포레이티드 Compositions for enhancing nail growth

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010042324A (en) * 1998-03-31 2001-05-25 차알스 제이. 메츠 An acidified composition for topical treatment of nail and skin conditions
KR20040090045A (en) * 2003-04-16 2004-10-22 바이오존 주식회사 Antimicrobial composition comprising grape fruit seed extract, sodium bicarbonate, glycine, and undecylenic acid (or its Na salt) and the preparation method thereof
KR20110123739A (en) * 2009-01-08 2011-11-15 알러간, 인코포레이티드 Compositions for enhancing nail growth

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"TaeKyungchemical, Download, information", 22 April 2008 (2008-04-22), Retrieved from the Internet <URL:http://www.taekyungchemi.com/inopds/bbsread.php?code-pds0l&nbd=pds0l&uid-93&page=1&start=0&thread=87&no=65&field=&key=&mode=&login_mode=&listcount=&dbcal-no&lng-kor> *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104998007A (en) * 2015-07-21 2015-10-28 卢秀花 Traditional Chinese medicine fumigation lotion for treating genital candida

Also Published As

Publication number Publication date
KR101281470B1 (en) 2013-07-03

Similar Documents

Publication Publication Date Title
WO2014104577A1 (en) Composition including castor oil extracted from castor beans using hexane, undecylenic acid, propyl alcohol, propylene glycol, and water for external use on skin for preventing or treating athlete&#39;s foot
JP4976636B2 (en) Antipruritic composition and composition for promoting wound healing
DE60005152T2 (en) MEDICINAL PRODUCTS, FOOD ADDITIVES AND COSMETIC PREPARATION CONTAINING A FATTY ACID AND GINGER
JP2003515615A (en) Antimicrobial composition for treatment
EA018425B1 (en) Pharmaceutical, disinfectant or preservation extract of trigonella foenum-graecum, method for preparing and use thereof
JP2008517052A (en) Composition comprising extract of flower and tora tree and use thereof
CN109453094B (en) Mosquito-repelling and itching-relieving composition and skin care product containing composition
KR100682979B1 (en) Composition for precaution treatment having synergism for antimicrobial infection and antiinflammatory action and treatment for athletes foot provided by using them
CN107496792A (en) A kind of gel of antiphlogistic antibacterial treatment onychomycosis and preparation method thereof
JPS62126128A (en) External preparation composition
WO2019009663A1 (en) Composition for preventing and ameliorating athlete&#39;s foot
CN111040896A (en) Antibacterial, anti-inflammatory and skin-beautifying handmade soap
Firdaus et al. Dermatophytosis (Qooba) a misnomer infection and its management in modern and unani perspective-A comparative review
CN109758562B (en) Zedoary composite essential oil and preparation method and application thereof
KR20210044762A (en) Anti-microbial composition comprising pinus koraiensis sieb extract
KR100807842B1 (en) Anti-fungal composition for deodorization
KR20190025376A (en) Cosmetic composition for skin antioxidant or improving skin wrinkle comprising extracts of artemisiae argyi folium and cordyceps militaris
CN113925907A (en) Antibacterial anti-inflammatory and antiallergic composition as well as preparation method and application thereof
KR20110121295A (en) Composition of external skin preparation for alleviation of menstrual cramp
Rani et al. Ethnomedicinal, Pharmacological and Phytochemical Screening of Supari (Areca catechu Linn.): A Review
KR100787634B1 (en) Cosmetic composition having antiseptic activity
CN105326875B (en) A kind of natural nonreactive moisturizing disinfectant liquid for skin and preparation method thereof
CN104000919A (en) Traditional Chinese medicine composition
JP6590233B1 (en) Skin disease therapeutic agent and method for producing the same
CN108066518A (en) A kind of dog Chinese medicine bath lotion composition and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13867004

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13867004

Country of ref document: EP

Kind code of ref document: A1